Global Financial Private Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$4.2M Buy
71,504
+31,295
+78% +$1.87M 0.26% 98
2020
Q1
$2.24M Sell
40,209
-3,625
-8% -$222K 0.14% 133
2019
Q4
$2.81M Sell
43,834
-3,922
-8% -$225K 0.14% 150
2019
Q3
$2.42M Sell
47,756
-1,604
-3% -$75.4K 0.12% 168
2019
Q2
$2.24M Sell
49,360
-8,555
-15% -$398K 0.11% 181
2019
Q1
$2.76M Buy
57,915
+453
+0.8% +$22.6K 0.13% 158
2018
Q4
$2.99M Sell
57,462
-2,370
-4% -$127K 0.16% 130
2018
Q3
$3.71M Buy
59,832
+56,002
+1,462% +$3.32M 0.13% 143
2018
Q2
$212K Sell
3,830
-17,862
-82% -$965K 0.01% 505
2018
Q1
$1.37M Sell
21,692
-11,907
-35% -$766K 0.05% 228
2017
Q4
$2.06M Sell
33,599
-2,319
-6% -$145K 0.07% 176
2017
Q3
$2.29M Buy
+35,918
New +$2.1M 0.08% 157

Other funds holding BMY

Global Financial Private Capital's BMY Position: Q2 2020 in Review

Global Financial Private Capital increased its Bristol-Myers Squibb (BMY) stake by 78% in Q2 2020, buying an estimated $1.87M and bringing the position to 71,504 shares worth $4.2M. The position accounts for 0.26% of the portfolio, ranked #98.

Global Financial Private Capital first reported a position in BMY in Q3 2017 and has held it in 12 quarters since. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

  • Global Financial Private Capital held 71,504 shares of Bristol-Myers Squibb worth $4.2M as of Q2 2020.
  • Global Financial Private Capital bought 31,295 Bristol-Myers Squibb shares in Q2 2020, an estimated $1.87M.
  • Bristol-Myers Squibb made up 0.26% of Global Financial Private Capital's portfolio in Q2 2020, its #98 holding.
  • Global Financial Private Capital first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 12 quarters since.
  • 2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.